Vigilent Labs Plans $104.6 Million Headquarters & Operations Campus in North Charleston, South Carolina
Vigilent Labs’ new operations will serve as the company’s headquarters, which will include its East Coast production and manufacturing operations. Specifically, the company will work with its partners, SeroClinix and Leinco, to produce rapid COVID-19 antibody and antigen test kits. These FDA-approved and emergency use authorized test kits are cost-effective and will produce fast and accurate results in seven to 10 minutes. The new facility will begin manufacturing activities in December.
The Coordinating Council for Economic Development has awarded a $1 million Set-Aside grant to Charleston County to assist with costs related to this project. In addition, Vigilent Labs is working with readySC to assist in recruiting and training prospective employees.
“We are so honored by this substantial support from Governor McMaster, Secretary Hitt, the Coordinating Council and Charleston County to center our Vigilent Labs at the historic Charleston Navy Yard in South Carolina. This new facility will specialize in state-of-the-art health and bio-threat testing, screening technologies and products that will help address the expanding need for reliable and accurate COVID-19 testing to confront this pandemic. The Governor, Secretary of Commerce, Charleston County and their teams truly went above and beyond the call of duty to welcome us, attract us and support us, and we are so proud to claim South Carolina as home,” Vigilent Labs President John Falk said.
“Companies like Vigilent Labs continue to come to our state and invest in our people because of all that South Carolina has to offer. We are thankful for Vigilent Labs’ decision to invest more than $104.6 million and create over 400 new jobs here in South Carolina, and I look forward to seeing what the future will bring for this fantastic company and its leadership,” said Governor Henry McMaster.
Established in 2019, Vigilent Labs provides unique solutions to the detection, identification and assessment of health and bio-threats. The company’s team has substantial experience in the development of medical and bio-surveillance technologies as well as medical devices.
“Vigilent Labs is committed to providing next-generation solutions to address current and future biological threats, and their announcement to establish operations in North Charleston is a win for our community. This is important work and supports a promising future for Charleston County in the technology and life sciences sectors,” said Charleston County Economic Development Executive Director Steve Dykes.
Taiwan-Based Bora Pharmaceuticals Plans Manufacturing Complex in Mississauga, Ontario, Canada
Boom in E-Commerce Creating Workforce Opportunities
Finding the Sweet Spot in Food Plant Location Decisions
Cold Storage Is Hotter Than Ever
Expanded Incentives Support the Growth in Remote Work
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
34th Annual Corporate Survey & the 16th Annual Consultants Survey